---
reference_id: "PMID:27509100"
title: Randomized Trial of Thymectomy in Myasthenia Gravis.
authors:
- Wolfe GI
- Kaminski HJ
- Aban IB
- Minisman G
- Kuo HC
- Marx A
- Ströbel P
- Mazia C
- Oger J
- Cea JG
- Heckmann JM
- Evoli A
- Nix W
- Ciafaloni E
- Antonini G
- Witoonpanich R
- King JO
- Beydoun SR
- Chalk CH
- Barboi AC
- Amato AA
- Shaibani AI
- Katirji B
- Lecky BR
- Buckley C
- Vincent A
- Dias-Tosta E
- Yoshikawa H
- Waddington-Cruz M
- Pulley MT
- Rivner MH
- Kostera-Pruszczyk A
- Pascuzzi RM
- Jackson CE
- Garcia Ramos GS
- Verschuuren JJ
- Massey JM
- Kissel JT
- Werneck LC
- Benatar M
- Barohn RJ
- Tandan R
- Mozaffar T
- Conwit R
- Odenkirchen J
- Sonett JR
- Jaretzki A 3rd
- Newsom-Davis J
- Cutter GR
- MGTX Study Group
journal: N Engl J Med
year: '2016'
doi: 10.1056/NEJMoa1602489
content_type: abstract_only
---

# Randomized Trial of Thymectomy in Myasthenia Gravis.
**Authors:** Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BR, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJ, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki A 3rd, Newsom-Davis J, Cutter GR, MGTX Study Group
**Journal:** N Engl J Med (2016)
**DOI:** [10.1056/NEJMoa1602489](https://doi.org/10.1056/NEJMoa1602489)

## Content

1. N Engl J Med. 2016 Aug 11;375(6):511-22. doi: 10.1056/NEJMoa1602489.

Randomized Trial of Thymectomy in Myasthenia Gravis.

Wolfe GI(1), Kaminski HJ(1), Aban IB(1), Minisman G(1), Kuo HC(1), Marx A(1), 
Ströbel P(1), Mazia C(1), Oger J(1), Cea JG(1), Heckmann JM(1), Evoli A(1), Nix 
W(1), Ciafaloni E(1), Antonini G(1), Witoonpanich R(1), King JO(1), Beydoun 
SR(1), Chalk CH(1), Barboi AC(1), Amato AA(1), Shaibani AI(1), Katirji B(1), 
Lecky BR(1), Buckley C(1), Vincent A(1), Dias-Tosta E(1), Yoshikawa H(1), 
Waddington-Cruz M(1), Pulley MT(1), Rivner MH(1), Kostera-Pruszczyk A(1), 
Pascuzzi RM(1), Jackson CE(1), Garcia Ramos GS(1), Verschuuren JJ(1), Massey 
JM(1), Kissel JT(1), Werneck LC(1), Benatar M(1), Barohn RJ(1), Tandan R(1), 
Mozaffar T(1), Conwit R(1), Odenkirchen J(1), Sonett JR(1), Jaretzki A 3rd(1), 
Newsom-Davis J(1), Cutter GR(1); MGTX Study Group.

Collaborators: Cutter GR, Aban IB, Minisman G, Feese M, Kuo HC, Newsom-Davis J, 
Wolfe GI, Kaminski HJ, Jaretzki A 3rd, Sonett JR, Mazia C, Saluto V, Rosenberg 
M, Alvarez V, Rey L, King J, Butzkueven H, Goldblatt J, Carey J, Pollard J, 
Reddel S, Handel N, McCaughan B, Pallot L, Waddington-Cruz M, Novis R, 
Boasquevisque C, Dias-Tosta E, Morato-Fernandez R, Ximenes M, Werneck L, Scola 
R, Soltoski P, Chalk C, Moore F, Mulder D, Wadup L, Oger J, Mezei M, Evans K, 
Jiwa T, Schaffar A, White C, Toth C, Gelfand G, Wood S, Pringle E, Zwicker J, 
Maziak D, Shamji F, Sundaresan S, Seely A, Cea G, Verdugo R, Aguayo A, Jander S, 
Zickler P, Klein M, Marx A, Ströbel P, Weis CA, Melms A, Bischof F, Aebert H, 
Ziemer G, Nix W, Thümler B, Wilhem-Schwenkmezger T, Mayer E, Schalke B, Pöschel 
P, Hieber G, Wiebe K, Antonini G, Clemenzi A, Ceschin V, Rendina E, Venuta F, 
Morino S, Bucci E, Durelli L, Tavella A, Clerico M, Contessa G, Borasio P, Evoli 
A, Servidei S, Granone P, Mantegazza R, Berta E, Novellino L, Spinelli L, 
Motomura M, Matsuo H, Nagayasu T, Yoshikawa H, Takamori M, Oda M, Matsumoto I, 
Furukawa Y, Noto D, Motozaki Y, Iwasa K, Yanase D, Ramos GG, Cacho B, de la 
Garza L, Kostera-Pruszczyk A, Lipowska M, Kwiecinski H, Potulska-Chromik A, 
Orlowski T, Silva A, Feijo M, Freitas A, Heckmann J, Frost A, Pan EL, Tucker L, 
Rossouw J, Drummond F, Illa I, Diaz J, Leon C, Yeh JH, Chiu HC, Hsieh YS, 
Witoonpanich R, Tunlayadechanont S, Attanavanich S, Verschuuren J, Straathof C, 
Titulaer M, Versteegh M, Pels A, Krum Y, Buckley C, Leite M, Vincent A, 
Hilton-Jones D, Ratnatunga C, Newsom-Davis J, Farrugia ME, Petty R, Overell J, 
Kirk A, Gibson A, McDermott C, Hopkinson D, Lecky B, Watling D, Marshall D, 
Saminaden S, Davies D, Dougan C, Sathasivam S, Page R, Marshall D, Sussman J, 
Ealing J, Krysiak P, Amato A, Salajegheh M, Jaklitsch M, Roe K, Ashizawa T, 
Smith RG, Zwischenberg J, Stanton P, Barboi A, Jaradeh S, Tisol W, Gasparri M, 
Haasler G, Yellick M, Dennis C, Barohn R, Pasnoor M, Dimachkie M, McVey A, 
Gronseth G, Dick A, Kramer J, Currence M, Herbelin L, Belsh J, Li G, Langenfeld 
J, Mertz MA, Benatar M, Harrison T, Force S, Usher S, Beydoun S, Lin F, 
DeMeester S, Akhter S, Malekniazi A, Avenido G, Crum B, Milone M, Cassivi S, 
Fisher J, Ciafaloni E, Heatwole C, Watson T, Hilbert J, Smirnow A, Distad B, 
Weiss M, Wood D, Haug J, Ernstoff R, Cao J, Chmielewski G, Welsh R, Duris R, 
Gutmann L, Pawar G, Graeber GM, Altemus P, Nance C, Gutmann L, Jackson C, Grogan 
P, Calhoon J, Kittrell P, Myers D, Kaminski H, Hayat G, Naunheim K, Eller S, 
Holzemer E, Katirji B, Alshekhlee A, Robke J, Karlinchak B, Katz J, Miller R, 
Roan R, Forshew D, Kissel J, Elsheikh B, Ross P, Chelnick S, Lewis R, Acsadi A, 
Baciewicz F, Masse S, Massey J, Juel V, Onaitis M, Lowe J, Lipscomb B, Mozaffar 
T, Thai G, Milliken J, Martin V, Karayan R, Muley S, Parry G, Shumway S, Oh S, 
Claussen G, Lu L, Cerfolio R, Young A, Morgan M, Pascuzzi R, Kincaid J, Kesler 
K, Guingrich S, Michaels A, Phillips L, Burns T, Jones D, Fischer C, Pulley M, 
Berger A, D'Agostino H, Smith L, Rivner M, Pruitt J, Landolfo K, Hillman D, 
Shaibani A, Sermas A, Ruel R, Ismail F, Sivak M, Goldstein M, Camunas J, Bratton 
J, Tandan R, Panitch H, Leavitt B, Jones M, Wolfe G, Muppidi S, Vernino S, 
Nations S, Meyer D, Gorham N.

Author information:
(1)From the Department of Neurology, University at Buffalo Jacobs School of 
Medicine and Biomedical Sciences, Buffalo (G.I.W.), the Department of Neurology, 
University of Rochester Medical Center, Rochester (E.C.), and the Section of 
General Thoracic Surgery, Columbia University Medical Center, New York (J.R.S., 
A.J.) - all in New York; the Department of Neurology, George Washington 
University School of Medicine and Health Sciences, Washington, DC (H.J.K.); the 
Department of Biostatistics, University of Alabama at Birmingham, Birmingham 
(I.B.A., G.M., H.-C.K., G.R.C.); the Institute of Pathology, University Medical 
Center Mannheim, University of Heidelberg, Mannheim (A.M.), the Institute of 
Pathology, University of Göttingen, Göttingen (P.S.), and the Department of 
Neurology, Johannes Gutenberg University, Mainz (W.N.) - all in Germany; the 
Department of Neurology, University of Buenos Aires, Buenos Aires (C.M.); the 
Division of Neurology, University of British Columbia, Vancouver (J. Oger), and 
the Department of Neurology, McGill University, Montreal (C.H.C.) - both in 
Canada; the Department of Neurology, University of Chile, Santiago (J.G.C.); the 
Division of Neurology, Department of Medicine, University of Cape Town, Cape 
Town, South Africa (J.M.H.); the Department of Neurology, Catholic University 
(A.E.), and the Department of Neurosciences, Mental Health and Sensory Organs, 
Sapienza University of Rome (G.A.) - both in Rome; the Division of Neurology, 
Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (R.W.); the 
Department of Neurology, University of Melbourne, Melbourne, VIC, Australia 
(J.O.K.); the Department of Neurology, University of Southern California, Los 
Angeles (S.R.B.), and the Department of Neurology, University of California 
Irvine Medical Center, Orange (T.M.) - both in California; the Department of 
Neurology, Medical College of Wisconsin, Milwaukee (A.C.B.); the Department of 
Neurology, Harvard Medical School, Boston (A.A.A.); Nerve and M

Erratum in
    N Engl J Med. 2017 May 25;376(21):2097. doi: 10.1056/NEJMx170003.. [Dosage 
error in article text].

Comment in
    N Engl J Med. 2016 Aug 11;375(6):576-7. doi: 10.1056/NEJMe1607953.
    Chirurg. 2016 Dec;87(12):1080. doi: 10.1007/s00104-016-0323-x.
    J Neurosurg Anesthesiol. 2017 Jan;29(1):74-75. doi: 
10.1097/ANA.0000000000000381.
    J Thorac Dis. 2016 Oct;8(10):E1375-E1378. doi: 10.21037/jtd.2016.10.15.
    J Thorac Dis. 2016 Oct;8(10):E1420-E1422. doi: 10.21037/jtd.2016.10.03.
    N Engl J Med. 2016 Nov 17;375(20):2006-2007. doi: 10.1056/NEJMc1611704.
    N Engl J Med. 2016 Nov 17;375(20):2005. doi: 10.1056/NEJMc1611704.
    N Engl J Med. 2016 Nov 17;375(20):2006. doi: 10.1056/NEJMc1611704.
    J Thorac Dis. 2016 Nov;8(11):3003-3005. doi: 10.21037/jtd.2016.11.88.
    N Engl J Med. ;375(20):2005-2006. doi: 10.1056/NEJMc1611704.
    Ann Transl Med. 2016 Dec;4(24):526. doi: 10.21037/atm.2016.12.54.
    J Thorac Dis. 2017 Feb;9(2):237-239. doi: 10.21037/jtd.2017.02.32.

BACKGROUND: Thymectomy has been a mainstay in the treatment of myasthenia 
gravis, but there is no conclusive evidence of its benefit. We conducted a 
multicenter, randomized trial comparing thymectomy plus prednisone with 
prednisone alone.
METHODS: We compared extended transsternal thymectomy plus alternate-day 
prednisone with alternate-day prednisone alone. Patients 18 to 65 years of age 
who had generalized nonthymomatous myasthenia gravis with a disease duration of 
less than 5 years were included if they had Myasthenia Gravis Foundation of 
America clinical class II to IV disease (on a scale from I to V, with higher 
classes indicating more severe disease) and elevated circulating concentrations 
of acetylcholine-receptor antibody. The primary outcomes were the time-weighted 
average Quantitative Myasthenia Gravis score (on a scale from 0 to 39, with 
higher scores indicating more severe disease) over a 3-year period, as assessed 
by means of blinded rating, and the time-weighted average required dose of 
prednisone over a 3-year period.
RESULTS: A total of 126 patients underwent randomization between 2006 and 2012 
at 36 sites. Patients who underwent thymectomy had a lower time-weighted average 
Quantitative Myasthenia Gravis score over a 3-year period than those who 
received prednisone alone (6.15 vs. 8.99, P<0.001); patients in the thymectomy 
group also had a lower average requirement for alternate-day prednisone (44 mg 
vs. 60 mg, P<0.001). Fewer patients in the thymectomy group than in the 
prednisone-only group required immunosuppression with azathioprine (17% vs. 48%, 
P<0.001) or were hospitalized for exacerbations (9% vs. 37%, P<0.001). The 
number of patients with treatment-associated complications did not differ 
significantly between groups (P=0.73), but patients in the thymectomy group had 
fewer treatment-associated symptoms related to immunosuppressive medications 
(P<0.001) and lower distress levels related to symptoms (P=0.003).
CONCLUSIONS: Thymectomy improved clinical outcomes over a 3-year period in 
patients with nonthymomatous myasthenia gravis. (Funded by the National 
Institute of Neurological Disorders and Stroke and others; MGTX 
ClinicalTrials.gov number, NCT00294658.).

DOI: 10.1056/NEJMoa1602489
PMCID: PMC5189669
PMID: 27509100 [Indexed for MEDLINE]